ZURICH, Feb 16 (Reuters) - Swiss drugmaker Roche ROG.VX said on Friday it had filed its flu drug Tamiflu for approval for use in children in smaller 30 and 45 mg doses in Europe and would do the same in the United States soon.
“Roche has been granted an accelerated review and is optimistic that EMEA will complete their evaluation by mid-year,” the company said in a statement.
Roche said it had already registered Tamiflu — which his stockpiled in countries across the world to fight a possible pandemic of birdflu — in 75 mg capsules, Roche said.
((Reporting by Douwe Miedema
Telephone: 41 1 631 7340)) Keywords: ROCHE TAMIFLU/
C Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWEA1789